Advertisement
Journal Home
Search for

Volume 46, Issue 3, Pages 195-199 (March 2010)


View previous. 11 of 15 View next.

Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland

Nazmiye DinceraCorresponding Author Informationemail address, Gaye Güler Tezela, Arzu Sungura, Cigdem Himmetoglua, Kay Huebnerb, Gülnur Gülera

Received 6 October 2009; received in revised form 7 December 2009; accepted 8 December 2009. published online 11 January 2010.

Abstract 

Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC) are salivary gland neoplasms with divergent morphological features and clinical behavior. ACC is a basaloid tumor whereas MEC is a glandular epithelial neoplasm. FHIT and WWOX are tumor suppressor genes that encompass the FRA3B and FRA16D fragile sites at chromosomes 3p14.2 and 16q23.3, respectively. In previous studies, we have shown concordant loss of Fhit and Wwox expression in breast cancer, with significantly more frequent loss in cancers of basal-like phenotype. To determine if there is a similar association in salivary gland neoplasms, we designed a study of MEC and ACC of salivary gland on tissue microarrays (TMA). TMAs were constructed from 25 MEC and 19 ACC of salivary gland. Fhit and Wwox protein expression was assessed by immunohistochemical staining of cores on TMAs. Correlations among immunohistochemical markers and histological type were determined by statistical analyses. Significantly reduced Fhit and Wwox expression was observed in ACC (p=0.002 and p<0.001, respectively). The results suggest that, as for breast cancer, loss of Fhit and Wwox expression might have a role in the pathogenesis of basaloid differentiation in salivary gland neoplasms; alternatively, differences in chromatin structure at chromosome fragile regions might make fragile genes more accessible to DNA damage and rearrangement early during preneoplastic stages of basaloid cancers. Studies of basaloid tumors of other organ systems may show similar results and these findings may have implications for treatment modalities designed for basal-like tumors.

a Hacettepe University, Faculty of Medicine, Department of Pathology, Ankara, Turkey

b Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

Corresponding Author InformationCorresponding author. Address: Department of Pathology, Hacettepe University, Faculty of Medicine, Sihhiye, Ankara 06100, Turkey. Tel.: +90 532 618 35 60; fax: +90 312 312 69 55.

PII: S1368-8375(09)00999-3

doi:10.1016/j.oraloncology.2009.12.003


View previous. 11 of 15 View next.

Advertisement